In agree with the results in the present study, treatment of REV-ERBα agonist SR9009 decreased the level of cleaved caspase-3 and the number of TUNEL-positive cells in the hippocampus in mice with the pilocarpine-induced status epilepticus 32. This evidence concerns the gene NR1D1 and status epilepticus.